#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage III Lupus nephritis Systemic scleroderma Thrombotic microangiopathy Prader-Willi syndrome Nodal marginal zone B-cell lymphoma Thalassaemia Hepatoblastoma Necrotising myositis Prolymphocytic leukaemia Primary biliary cholangitis Adenocarcinoma pancreas Mantle cell lymphoma Neuroendocrine cell hyperplasia of infancy Colitis ulcerative More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Trials in Disease Mantle cell lymphoma stage II – Life with Disease Acquired haemophilia – Trials in Disease Fabry’s disease – Life with Disease Von Willebrand’s disease – Trials in Disease Hereditary neuropathic amyloidosis – Basic Information Chondrosarcoma – Trials in Disease Krabbe’s disease – Trials in Disease Haemophilia B without inhibitors – Life with Disease Pulmonary sarcoidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Isaralgagene Civaparvovec Englumafusp Alfa Cobimetinib Festuca Elatior Pollen Extract Iptacopan Fluindione Daplusiran RP2 S230815-2 Amivantamab F510/08 Siponimod Dabigatran AAV9-CTNT-COBAG3 Methylprednisolone Aceponate A/(H3N2)-LIKE VIRUS ANTIGEN Specific Nucleic Acid Sna-Xfsc Thiamine Nitrate Bp Tramazoline Hydrochloride Radotinib Dihydrochloride More therapies…

    Learn about Your Condition

    Neurodevelopmental disorder Metabolic surgery Hyponatraemia Hyperkalaemia Chondrosarcoma metastatic Pulmonary tuberculosis Turner's syndrome Nocturia Thromboembolectomy Urinary incontinence Nephroblastoma Diabetes mellitus Pancreatic carcinoma Psoriatic arthropathy Bartonellosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ovarian epithelial cancer

  • Study on the Effectiveness and Safety of Cyclophosphamide Monohydrate and Drug Combination for Patients with Persistent or Recurrent Rare Epithelial Ovarian Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Giredestrant
    • Inavolisib
    • Ipatasertib
    Czechia France Germany Italy Spain

  • Study on Niraparib’s Effects and Safety in Patients with High-Grade Serous Ovarian Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    France

  • Study on Sentinel Node Detection Using Technetium-99m and Indocyanine Green in Patients with Early-Stage Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Technetium (99Mtc)
    • Human Serum Albumin
    • Pertechnetate (99Mtc) Sodium
    Spain

  • Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Prednisolone Acetate
    • Carboplatin
    Belgium Ireland Spain

  • Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Bevacizumab
    • Carboplatin
    Belgium Czechia France Germany Hungary Italy +2

  • Study of Mirvetuximab Soravtansine compared to standard chemotherapy in women with platinum-resistant advanced ovarian cancer with high folate receptor expression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Peritoneal sarcoma
    • Fallopian tube cancer
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Prednisolone Acetate
    • Topotecan
    France
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!